IL150865A0 - Dual inhibitors of cholesterol ester and wax ester synthesis for sebaceous gland disorders - Google Patents
Dual inhibitors of cholesterol ester and wax ester synthesis for sebaceous gland disordersInfo
- Publication number
- IL150865A0 IL150865A0 IL15086501A IL15086501A IL150865A0 IL 150865 A0 IL150865 A0 IL 150865A0 IL 15086501 A IL15086501 A IL 15086501A IL 15086501 A IL15086501 A IL 15086501A IL 150865 A0 IL150865 A0 IL 150865A0
- Authority
- IL
- Israel
- Prior art keywords
- ester
- sebaceous gland
- dual inhibitors
- gland disorders
- synthesis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17977800P | 2000-02-02 | 2000-02-02 | |
| PCT/US2001/002190 WO2001056556A2 (fr) | 2000-02-02 | 2001-01-23 | Doubles inhibiteurs de la synthese d'ester de choslesteryle et d'ester de cire utilises dans le traitement des troubles des glandes sebacees |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL150865A0 true IL150865A0 (en) | 2003-02-12 |
Family
ID=22657957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15086501A IL150865A0 (en) | 2000-02-02 | 2001-01-23 | Dual inhibitors of cholesterol ester and wax ester synthesis for sebaceous gland disorders |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US6730703B2 (fr) |
| EP (1) | EP1263421B1 (fr) |
| JP (1) | JP2003531113A (fr) |
| KR (1) | KR20020073574A (fr) |
| CN (1) | CN1398182A (fr) |
| AP (1) | AP2002002612A0 (fr) |
| AT (1) | ATE295724T1 (fr) |
| AU (1) | AU781563B2 (fr) |
| BG (1) | BG107042A (fr) |
| BR (1) | BR0107954A (fr) |
| CA (1) | CA2398219A1 (fr) |
| CR (1) | CR6712A (fr) |
| DE (1) | DE60110897T2 (fr) |
| DZ (1) | DZ3288A1 (fr) |
| EA (1) | EA004255B1 (fr) |
| EE (1) | EE200200429A (fr) |
| ES (1) | ES2239145T3 (fr) |
| GE (1) | GEP20043286B (fr) |
| HR (1) | HRP20020717A2 (fr) |
| HU (1) | HUP0301010A3 (fr) |
| IL (1) | IL150865A0 (fr) |
| IS (1) | IS6478A (fr) |
| MA (1) | MA26872A1 (fr) |
| MX (1) | MXPA02007309A (fr) |
| NO (1) | NO20023659L (fr) |
| NZ (1) | NZ520330A (fr) |
| OA (1) | OA12173A (fr) |
| PL (1) | PL357041A1 (fr) |
| PT (1) | PT1263421E (fr) |
| SK (1) | SK10972002A3 (fr) |
| UA (1) | UA75345C2 (fr) |
| WO (1) | WO2001056556A2 (fr) |
| YU (1) | YU57502A (fr) |
| ZA (1) | ZA200206075B (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1281399A3 (fr) * | 2001-08-01 | 2004-02-11 | Warner-Lambert Company | Inhibiteurs doubles de la synthèse des des esters de cires et des esters du cholestérol pour inhiber la production de sébum |
| US20050031699A1 (en) | 2003-06-26 | 2005-02-10 | L'oreal | Porous particles loaded with cosmetically or pharmaceutically active compounds |
| ES2313065T3 (es) | 2003-10-09 | 2009-03-01 | Warner-Lambert Company Llc | Composiciones farmaceuticas que comprenden derivados de malonamida para disminuir la produccion de sebo. |
| AU2006217529C1 (en) | 2005-02-24 | 2013-03-07 | Medicis Pharmaceutical Corporation | Crystalline ACAT inhibitor |
| FR2904002A1 (fr) * | 2006-07-19 | 2008-01-25 | Galderma Res & Dev S N C Snc | Modulateurs de la lanosterol synthetase dans le traitement de l'acne ou de l'hyperseborrhee |
| FR2903999B1 (fr) * | 2006-07-19 | 2008-09-05 | Galderma Res & Dev S N C Snc | Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee |
| FR2938342A1 (fr) * | 2008-11-13 | 2010-05-14 | Galderma Res & Dev | Ciblage de modulateurs de ces1 et/ou ces3 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee |
| US20100226983A1 (en) | 2009-01-28 | 2010-09-09 | Nanobio Corporation | Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof |
| BR112020025208A2 (pt) * | 2018-06-21 | 2021-03-09 | Dermavant Sciences GmbH | Formulações tópicas de inibidores de dgat1 e seus métodos de uso |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4545977A (en) * | 1985-01-11 | 1985-10-08 | G. D. Searle & Co. | Compositions and methods for treating severe acne with isotretinoin |
| US4751026A (en) | 1986-03-24 | 1988-06-14 | Warner-Lambert Company | Substituted anilides of oleic, linoleic, or linolenic acid as inhibitors of acyl-coa:cholesterol acyltransferase |
| US4722927A (en) | 1986-04-28 | 1988-02-02 | Warner-Lambert Company | Pyrimidine amides of oleic or linoleic acid, composition containing them and their use as inhibitors of acyl-CoA cholesterol acyltransferase |
| EP0252524A3 (fr) | 1986-07-11 | 1989-04-19 | Warner-Lambert Company | Dérivés d'aryl- et aralkylamide d'acides oméga-(phényloxy substitué)-alcanoiques comme inhibiteurs d'acyl-CoA: cholestérol-acyltransférase et compositions pharmaceutiques les contenant |
| US4716175A (en) | 1987-02-24 | 1987-12-29 | Warner-Lambert Company | Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase |
| US5015644A (en) | 1987-06-02 | 1991-05-14 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds |
| IE61716B1 (en) | 1987-06-02 | 1994-11-30 | Warner Lambert Co | Antihyperlipidemic and antiatherosclerotic urea compounds |
| ATE61574T1 (de) | 1987-07-02 | 1991-03-15 | Warner Lambert Co | N-((2,6-disubstituierte)-phenyl>-harnstoff und - carbamat-inhibitoren der acyl-coenzym a:cholesterol-acyltransferase. |
| US5116848A (en) | 1988-03-30 | 1992-05-26 | Warner-Lambert Company | N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents |
| US4999373A (en) | 1988-03-30 | 1991-03-12 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| US4948806A (en) | 1988-03-30 | 1990-08-14 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| US5030653A (en) | 1988-03-30 | 1991-07-09 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| US4868210A (en) | 1988-03-30 | 1989-09-19 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| US5155127A (en) | 1989-02-09 | 1992-10-13 | Warner-Lambert Company | N-(substituted aryl)-n'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents |
| US4923896A (en) | 1989-02-09 | 1990-05-08 | Warner-Lambert Company | N-(substituted aryl)-N'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents |
| US4994465A (en) | 1989-02-17 | 1991-02-19 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic trisubstituted urea compounds |
| AU632809B2 (en) | 1989-05-25 | 1993-01-14 | Takeda Chemical Industries Ltd. | Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof |
| AU629376B2 (en) | 1989-08-04 | 1992-10-01 | Mitsubishi Chemical Corporation | 1-phenylalkyl-3-phenylurea derivatives |
| MX22406A (es) | 1989-09-15 | 1994-01-31 | Pfizer | Nuevos derivados de n-aril y n-heteroarilamidas y urea como inhibidores de acil coenzima a: acil transferasa del colesterol (acat). |
| TW205037B (fr) | 1989-10-06 | 1993-05-01 | Takeda Pharm Industry Co Ltd | |
| JPH05310678A (ja) | 1990-01-22 | 1993-11-22 | Mitsubishi Kasei Corp | １−フェニルアルキル−３−フェニル尿素誘導体 |
| US5362878A (en) | 1991-03-21 | 1994-11-08 | Pfizer Inc. | Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT) |
| ATE175196T1 (de) | 1992-01-23 | 1999-01-15 | Pfizer | 4-phenyl-3-(heteroarylureido)-1,2-dihydro-2- oxochinolin derivate, als antihypercholesterolemische und antiatherosklerotische mittel |
| KR950701621A (ko) | 1992-05-28 | 1995-04-28 | 알렌 제이. 스피겔 | 아실 조효소a : 콜레스테롤 아실 전이효소(acat)의 억제제로서 신규한 n- 아릴 및 n- 헤테로아릴우레아 유도체(new n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a : cholesterol acyl transferase(acat) |
| US5565472A (en) | 1992-12-21 | 1996-10-15 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
| US5491172A (en) | 1993-05-14 | 1996-02-13 | Warner-Lambert Company | N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| US5596001A (en) | 1993-10-25 | 1997-01-21 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)quinoline derivatves |
| US5494172A (en) * | 1994-05-12 | 1996-02-27 | Miller Compressing Company | Magnetic pulley assembly |
| US6133326A (en) * | 1994-08-31 | 2000-10-17 | Pfizer Inc | Compositions and methods for decreasing sebum production |
| AU763687B2 (en) * | 1998-06-25 | 2003-07-31 | Tularik Inc. | Arylsulfonanilide phosphates |
| JP2004513090A (ja) * | 2000-09-27 | 2004-04-30 | メルク エンド カムパニー インコーポレーテッド | 糖尿病及び脂質異常症の治療のためのベンゾピランカルボン酸誘導体 |
-
2001
- 2001-01-23 CA CA002398219A patent/CA2398219A1/fr not_active Abandoned
- 2001-01-23 CN CN01804520A patent/CN1398182A/zh active Pending
- 2001-01-23 JP JP2001556248A patent/JP2003531113A/ja active Pending
- 2001-01-23 MX MXPA02007309A patent/MXPA02007309A/es active IP Right Grant
- 2001-01-23 DZ DZ013288A patent/DZ3288A1/fr active
- 2001-01-23 PT PT01948936T patent/PT1263421E/pt unknown
- 2001-01-23 IL IL15086501A patent/IL150865A0/xx unknown
- 2001-01-23 WO PCT/US2001/002190 patent/WO2001056556A2/fr active IP Right Grant
- 2001-01-23 GE GEAP20016597A patent/GEP20043286B/en unknown
- 2001-01-23 EA EA200200764A patent/EA004255B1/ru not_active IP Right Cessation
- 2001-01-23 AP APAP/P/2002/002612A patent/AP2002002612A0/en unknown
- 2001-01-23 HU HU0301010A patent/HUP0301010A3/hu unknown
- 2001-01-23 NZ NZ520330A patent/NZ520330A/en unknown
- 2001-01-23 YU YU57502A patent/YU57502A/sh unknown
- 2001-01-23 UA UA2002076160A patent/UA75345C2/uk unknown
- 2001-01-23 PL PL01357041A patent/PL357041A1/xx not_active Application Discontinuation
- 2001-01-23 EE EEP200200429A patent/EE200200429A/xx unknown
- 2001-01-23 SK SK1097-2002A patent/SK10972002A3/sk not_active Application Discontinuation
- 2001-01-23 EP EP01948936A patent/EP1263421B1/fr not_active Expired - Lifetime
- 2001-01-23 DE DE60110897T patent/DE60110897T2/de not_active Expired - Fee Related
- 2001-01-23 OA OA1200200234A patent/OA12173A/en unknown
- 2001-01-23 US US10/182,847 patent/US6730703B2/en not_active Expired - Fee Related
- 2001-01-23 AU AU29718/01A patent/AU781563B2/en not_active Ceased
- 2001-01-23 BR BR0107954-9A patent/BR0107954A/pt not_active Application Discontinuation
- 2001-01-23 ES ES01948936T patent/ES2239145T3/es not_active Expired - Lifetime
- 2001-01-23 AT AT01948936T patent/ATE295724T1/de not_active IP Right Cessation
- 2001-01-23 KR KR1020027009943A patent/KR20020073574A/ko not_active Application Discontinuation
-
2002
- 2002-07-19 IS IS6478A patent/IS6478A/is unknown
- 2002-07-24 CR CR6712A patent/CR6712A/es not_active Application Discontinuation
- 2002-07-30 ZA ZA200206075A patent/ZA200206075B/en unknown
- 2002-08-01 MA MA26756A patent/MA26872A1/fr unknown
- 2002-08-01 NO NO20023659A patent/NO20023659L/no not_active Application Discontinuation
- 2002-08-29 BG BG107042A patent/BG107042A/bg unknown
- 2002-08-30 HR HR20020717A patent/HRP20020717A2/hr not_active Application Discontinuation
-
2004
- 2004-02-06 US US10/773,354 patent/US20040161393A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6445601A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| IL160648A0 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| IL160630A0 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| HUP0102782A3 (en) | Salycilanilide as inhibitors of transcription factor nf-kb | |
| AU2914202A (en) | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors | |
| ZA200206032B (en) | Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production. | |
| AU5309400A (en) | Methods and compositions for the treatment of neuroleptic and related disorders using sertindole derivatives | |
| HUP0105011A3 (en) | Synthesis method of nitroxymethylphenyl esters of aspirin derivatives | |
| AUPR101600A0 (en) | Compositions and methods for diagnosis and treatment of cardiovascular disorders | |
| IL150865A0 (en) | Dual inhibitors of cholesterol ester and wax ester synthesis for sebaceous gland disorders | |
| AU2002249983A1 (en) | Compositions and methods for diagnosis of neuropsychiatric disorders | |
| AU2002214038A1 (en) | Inhibitors of transglutaminases | |
| AU2252101A (en) | New synthesis of SPLA2 inhibitors | |
| AU2001270131A1 (en) | Screen for identifying inhibitors of glycosylphosphatidylnositol anchoring | |
| AU2001274413A1 (en) | Synthesis procedure for biphenylimidazolyl-(1)-phenylmethane and related compounds | |
| GB9817348D0 (en) | Pharmaceutical use of esters | |
| AU2002300319A1 (en) | Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production | |
| AU2001232734A1 (en) | Compositions containing potential spla2 inhibitors for the treatment of pain | |
| AU3075202A (en) | Compositions and methods for the discovery and selection of biological information | |
| AU2002218555A1 (en) | Operation system of exhibition site for internet | |
| DK1263421T3 (da) | Den dobbelte inhibitor af cholesterylester- og voksestersyntese avasimibe til behandling af talgkirtel-lidelser | |
| TW441838U (en) | Box structure of removable disk | |
| TW484609U (en) | Improved structure of placement box for disks | |
| AU2002257602A1 (en) | Simple method for the synthesis of boswellic acids and derivatives thereof | |
| AU2002246637A1 (en) | Compositions and methods for the treatment of diseases related to faulty cholesterol regulation |